twenty-seven of 37 patients with otherwise resistant cutaneous t-cell lymphoma responded to the treatment , with an average 64 percent decrease in cutaneous involvement after 22 +/- 10 weeks ( mean +/- sd ) .
C0079773
cutaneous t-cell lymphoma
C1511567
cutaneous involvement